News
The Global Prefilled Syringes Market is expected to witness a high single-digit growth rate by 2027. The growth of the prefilled syringes market is driven by an increasing prevalence of diverse ...
Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is building buzz with a new direct-to-consumer campaign. The “Treatment MY ...
The expanded interchangeability now applies to the 40mg prefilled syringe and the 40mg and 80mg autoinjectors, in addition to the 20mg and 80mg prefilled syringes. The Food and Drug Administration ...
SMi reports: West Pharmaceutical Services to Host a Free Exclusive Webinar on Prefilled Syringe Elastomer Components High-Quality Solutions for Sensitive Molecules, taking place on 16 th July 2020.
Additionally, the recent US approval of Vyvgart Hytrulo as a prefilled syringe for self-injection further enhances patient access and convenience compared with the intravenous infusion of Vyvgart.
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...
single-dose prefilled syringes. Zydus’ generic Glatiramer Acetate Injection is an FDA-approved, AP-rated substitutable generics of Copaxone ® 20 mg/ml, 40 mg/ml and indicated for the treatment ...
11d
MedPage Today on MSNFDA Approves Auto-Injector for Migraine, Cluster HeadacheThe FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...
Zydus Receives Final Approval From USFDA for Glatiramer Acetate Injection, the Generic Version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes Zydus Lifesciences Limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results